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Figure 2. A conceptual framework to explain
partial penetrance.
Removal of a component in a buffered sys-
tem results in a partially penetrant pheno-
type. In the example shown, 50% (2/4) of
the animals will display a mutant phenotype.
See [14] for an intriguing recent report on
the phenomenon of partially penetrant
phenotypes.
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R699(Figure 2). The enhancer studies fit
nicely into this picture. Two enhancers
ensure firing probability and/or
sufficient mRNA output above
a threshold even in the presence
of perturbations, while removal of
one enhancer decreases the firing
probability and/or level of mRNA
output to a threshold where
fluctuations result in a significantimpact in some but not all animals or
cells (Figure 2). The bottom line of all
this is quite simple and surely would
have pleased Spemann and
Waddington: having two copies of the
same thing is good, but the adaptive
advantage of such duplication may
only be apparent under specific,
perturbing conditions.
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In the early 1930s, the noted British
geneticist Lionel Penrose realized that
Down syndrome babies are far likelier
to be born to older women [1]. At
the time, Down syndrome was known
only as a form of mental retardation
with characteristic phenotypic
features. The understanding that the
condition results from three copies
of chromosome 21 (trisomy 21)
would not bemade for another 25 years
[2,3]. In short, the recognition that
advancing maternal age affects the
likelihood of producing a normal,
healthy child predated our
understanding that chromosome
abnormalities represent not only the
leading cause of birth defects inhumans, but also the major cause of
pregnancy loss.
The meiotic errors that result in
chromosome abnormalities are
common in humans, and
approximately 0.2–0.3% of newborn
infants are trisomic [4]. However,
this represents just the tip of a large
iceberg, because most aneuploid
conceptions die in utero. Indeed,
studies of preimplantation embryos
suggest that a large proportion, if not
a majority, of fertilized human eggs
have extra or missing chromosomes
[5]. Because the vast majority of
errors result from the fertilization of
a chromosomally abnormal egg by
a normal sperm, attention has focused
on why human female meiosis is so
error-prone.How does maternal age factor into
this equation? Hugely. Among women
in their twenties, approximately 2–3%
of clinically recognized pregnancies
involve trisomic fetuses but, among
women in their forties, this value
skyrockets to over 35% (Figure 1).
Given the importance of the age
effect and the research attention
devoted to it, it may seem odd
that we know so little about its
basis. Indeed, like the enigmatic
smile on the Mona Lisa, the
mechanism(s) by which maternal age
induces its effects on chromosome
segregation have remained
a tantalizing mystery. However,
three papers in this issue of Current
Biology [6–8] lend strong support to
amechanism involving the ties thatbind
meiotic chromosomes. Physical
connections — whether between
sister chromatids during mitosis or
between homologs and sister
centromeres during meiosis — are
essential for proper chromosome
segregation and depend on a class
of proteins known as the cohesins
[9,10]. The production of haploid
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Figure 1. Maternal age affects the incidence of trisomy in clinically recognized pregnancy.
(A) In the human female, the risk of a trisomic pregnancy is increased around the time of
menarche. The incidence decreases slightly by the late teens and a ‘flat line’ period of
10–15 years ensues during the prime reproductive years. This is followed by an exponential
increase in incidence in the mid 30s. (B) The association with age varies among chromosomes.
For example, trisomy 21 shows the characteristic exponential increase in the mid-thirties, but
trisomy 16 (the most common trisomy in miscarriages) shows a linear increase with age and
double trisomies are effectively limited to women in their 40s. (Modified from [20]; differences
in the axes between (A) and (B) reflect the limited sample sizes for individual trisomies).
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R700gametes requires a bit of cohesin
magic: duringmeiosis I, crossovers and
cohesion between arms lock
homologs together until anaphase I,
when degradation of all cohesin
except that between sister
kinetochores allows homologs to
segregate. At anaphase II, the
cohesion remaining between sister
kinetochores is lost, allowing sisters
to segregate (Figure 2A). These
specialized chromosome acrobatics
are accomplished by substituting
meiosis-specific players (i.e., REC8,
STAG3, andSMC1b) for threeof the four
components of the cohesin complex
and by the protection at the firstmeiotic
division of cohesin between sister
centromeres by Shugoshin, a highly
conserved family of proteins that also
function in mitotic cell division [11].
Cohesins are assembled on
chromosomes during S phase and
degraded at anaphase during every
cell division. But the situation in the
egg is unique because S phase takes
place during fetal development,
while the cell division itself does
not occur in humans until at least
adozenyears later. Thus, a fundamental
question is: does chromosome
segregation in the human egg depend
on a complex of cohesin proteins that ismany years old and could age-related
degradation of this complex at the first
meiotic division be the basis of the
human maternal age effect?
The paper by Revenkova et al. [6]
in this issue bears directly on the first
half of this question. Several years ago,
these investigators created a mouse
lacking a meiosis-specific cohesin
(i.e., the SMC1b-deficient mouse) and
provided the first direct evidence of an
age-related decline in chromosome
cohesion in mammalian oocytes [12].
Their current paper examines possible
age-related cohesion deterioration
using a mouse carrying a floxed Smc1b
gene and Cre recombinase under the
control of theGdf9gene. The strategy is
a clever one: the SMC1b protein is
made and incorporated into themeiotic
cohesin complex normally during
meiotic prophase in the fetal ovary.
However, because Gdf9 is expressed
shortly after birth, additional SMC1b
protein cannot be made during the
extended period of meiotic arrest or
during oocyte growth. Thus, if protein
turnover is critical for the maintenance
of cohesion, these females should be
in big trouble. Surprisingly, and in
marked contrast to the conventional
SMC1b-deficient mouse, the
conditional knockout female is fullyfertile and shows no signs of early
reproductive senescence. Moreover,
an analysis of metaphase I oocytes in
young and old females provided no
evidence of loss of cohesion. While
this study does not rule out the
possibility that new cohesin proteins
get incorporated into the complex,
it demonstrates beautifully that the
cohesionestablishedduringpremeiotic
S in the fetal ovary is sufficient to
maintain chromosome connections in
the mouse, even in old oocytes.
What about the second half of the
question — the possible association
between age-related degradation of
cohesin and increasing rate of
aneuploidy? The other two cohesin
papers in this issue [7,8] address this by
analyzing much older, naturally aged
females than those studied by
Revenkova et al. [6]. In the first, Richard
Schultz and Michael Lampson and
colleagues [7] conducted live cell
imaging and conventional cytological
studies of oocytes from young and very
old (>16 month old) B6D2F1/J females.
They first assessed centromere
cohesion, asking whether sister
centromeres were locked together
as closely in old as young oocytes. They
weren’t. In studies of cells atmetaphase
I and metaphase II they found that the
distance between sister kinetochores
was 25–50% greater in oocytes from
older females, suggesting an age-
related loss of centromere cohesion. An
analysis of REC8, the cohesin
component that is degraded at
anaphase, revealed an interesting age-
related difference: Although by western
analysis total protein levels were similar,
immunofluorescence staining of
chromosome-associated REC8
was much less intense in oocytes
ofolder females. Thisshouldpredispose
tomeiotic errors involving thepremature
separation of homologs (Figure 2B) and
sister chromatids (Figure 2C,D) and,
indeed, live cell imaging studies
confirmed this prediction.
The second paper by Mary Herbert
and her colleagues [8] took a slightly
different approach but reached
remarkably similar conclusions.
Examining 2 month old and 14 month
old females from a ‘long-lived’ strain of
mouse (C57BL/Icrfat) and focusing on
live cell imaging, they saw increases in
inter kinetochore distances, reductions
in REC8 signals, and increases in
anaphase defects in oocytes from old
females. In addition, they observed an
age-related depletion of SGO2, the
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Figure 2. Potential effects of premature cohesin loss on meiotic chromosome segregation.
The largeschematicon the left depictsapair of homologswith a singledistal crossover. (A)During
normal meiosis, cohesion (denoted in red) is lost sequentially; arm cohesion is lost at anaphase I,
allowing homologs to segregate to opposite spindle poles (arrows), but cohesion between sister
centromeres is retained to facilitate the orientation and segregation of sister chromatids at
anaphase II. (B) Premature loss of arm cohesion would make homologs with a single crossover
near the end of the chromosome arm particularly vulnerable to error; i.e., loss of their physical
connection would allow homologs to segregate independently, and segregation to the same
spindle pole would result in both copies of the chromosome in the metaphase II arrested egg
and none in the polar body (or vice versa). Normal segregation of sister chromatids at the second
meioticdivision following fertilizationwould result ina trisomicconceptus. (C,D)Premature lossof
the connections between sister centromeres could create a variety of problems, depending upon
the timing of the loss. (C) Loss occurring during the first meiotic division would allow sister kinet-
ochores to act independently. In this example, loss of sister centromere cohesion in one homolog
results in theproper segregationof onehomologand thepremature segregationof sister chroma-
tids at anaphase I in the other. This results in a missing chromatid in the polar body and an extra
chromatid in the egg (or vice versa). This imbalance can be corrected at the secondmeiotic divi-
sion if thesinglechromatid issegregated to thepolarbodybut if, asdepicted, it remains in theegg,
the conceptus would be trisomic. (D) Loss of centromere cohesion at anaphase I or duringmeta-
phase II arrestwoulddramatically increase the likelihoodof anerror at thesecondmeioticdivision
because sister chromatids would no longer be constrained to segregate from each other.
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R701protein necessary for preventing the
degradation of centromere cohesin at
anaphase I, suggesting another route
to aneuploidy.
The age-dependent loss of cohesin
reported in these studies of naturally
aged mice supports previous
observations from studies of cohesin
mutants inmice andDrosophila [13,14].
It also provides a plausible explanation
for awide spectrum of nondisjunctional
events — not just abnormalities
involving whole chromosomes at the
first meiotic division, but abnormalities
involving mis-segregation of sister
chromatids (Figure 2B–D). This is an
important consideration, since human
trisomies are thought to originate in
a variety of ways [15].
A role for premature cohesion loss
in meiotic errors seems indisputable,
but can we conclude that cohesin
degradation is the basis of the human
maternal age effect? Clearly
chronological age — the shear amount
of time spent in prophase arrest — is an
insufficient explanation, and in this
respect the naturally aged mouse
models provide important insight:
although both studies report a linear
age-related decline in chromosome
associated cohesins, the expected
increase in aneuploidy is only evident
in reproductively senescent females.
This suggests that physiological rather
than chronological age is the ultimate
culprit, an intellectually satisfying
conclusion for several reasons. First,
if time alone were the critical factor,
the 12+ years preceding puberty in
thehumanshouldensureamaternal age
effect by the timeof puberty. In addition,
although it is widely assumed that there
is a magic bullet — a single cause of the
maternal age effect — in fact, human
studies suggest multiple age effects,
some of which are unlikely to involve
abnormalities in cohesins [16]. Indeed,
the fact that the error rate is increased in
the human female at both extremes of
reproductive age (Figure 1A), that
different human chromosomes exhibit
strikingly different age curves
(Figure 1B), and that data from mouse
studies implicate other aspects of
physiological aging [17,18] combine to
suggest that factors other than
chronological age play a significant role.
The studies in this issue beg for direct
studies of cohesins in human oocytes
and, importantly, a recent study
provides just suchdata [19]. The results,
however, provide some surprising
counterpoints to the mouse data.Specifically, in studies of oocytes from
18–34 year old women, the authors
where unable to identify age-related
changes in immunolocalizationpatterns
of REC8, STAG3, or SMC1b. Thus,
direct evidence linking age-related
cohesin degradation to human
oogenesis is lacking, and this study
underscores the important point:
although premature loss of cohesion is
almost certainly an important
contributor, we still don’t understand
the physiological basis of maternal age-
related aneuploidy. In short, these
studiesprovidenewandexciting insight
with direct relevance to humans but,
for the time being, the Mona Lisasmile on the face of maternal age
remains intact.References
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Arise?Some patients can discriminate unseen visual stimuli within a field defect
caused by damage to the primary visual cortex. The pathways for this
‘blindsight’ have never been established, but recent studies implicate hitherto
overlooked cells in the thalamic LGN.Alan Cowey
The primary visual cortex, or V1, is the
major cortical destination of the input
from the eyes and contains a ‘map’
of the image on the retina. Hardly
surprising, then, that when it is partly
destroyed, as often happens following
stroke or traumatic injury to the back
of the brain, the patient has a visual
field defect in which he is clinically
blind — part of the map has been
deleted. Why the term ‘clinically blind’?
Why not just blind? The answer lies in
a controversy that began almost
a century ago between two eminent
British neurologists. Gordon Holmes [1]
concluded that, in the absence of part
of the striate cortex, the blindness is
complete, the field defect is absolute.
But George Riddoch [2], contemporary
and colleague, disagreed and argued
that such patients could perceive
motion within their otherwise blind
field. This controversy, like old
volcanoes, has rumbled on ever sinceand pervades much of the research
on what is now called blindsight.
Several investigators have studied
the role of V1 in monkeys, the visual
pathways of which closely resemble
our own. They have found an ever
increasing range of residual visual
sensitivity and discrimination within the
visual field defect caused by removing
part, or even all, of V1 (see [3] for
review) — not just reflexes such as
the pupillary response to light, but
also learned voluntary responses to
the orientation, shape, brightness,
size and motion of visual stimuli.
Unsurprisingly, monkeys, unlike human
patients, were considered to have
genuine residual vision and this was
attributed to the many other pathways
from the eye into the brain, as shown
schematically in Figure 1.
But a huge puzzle remained: why
don’t patients have the same abilities
given that they too have these other
pathways? The answer lies in the
different ways in which monkeys andpatients had been tested for decades.
Patients were asked whether they saw
anything in their field defects and with
the exception of motion— and perhaps
not even that — they said ‘‘No’’. But
monkeys were not asked this question.
Instead, and in order to get a reward,
they had to choose between two
visual stimuli — to make forced-choice
decisions. This difference was
highlighted when several investigators
[4,5], using forced-choice guessing,
demonstrated that patients were just as
good as monkeys, and Cowey and
Stoerig [6] showed that monkeys
categorized visual stimuli that they
coulddetect as being not like a light, but
invisible. In both cases the subjects
were showing ‘blindsight’, excellent
forcedchoiceperformance in the faceof
denial of consciously seeing anything.
Once the relevance of investigations
on monkeys to human blindsight was
established the search was renewed in
monkeys for the pathways that underlie
it. Did all the pathwaysshown in Figure 1
contribute or only one or a few? Early
work [7] showed that monkeyswith part
ofV1 removedcouldstillmove their eyes
to targetsconfined to thefielddefectbut
that this ability was destroyed if the
corresponding part of the superior
colliculus, which also has a ‘map’ of the
retina, was subsequently extirpated.
This still remains strong evidence that
the pathway from the eye to the superior
